Submission Details
| 510(k) Number | K231058 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 13, 2023 |
| Decision Date | January 04, 2024 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K231058 is an FDA 510(k) clearance for the Hudson RCI? AddiPak? Unit Dose Vial, a Nebulizer (direct Patient Interface) (Class II — Special Controls, product code CAF), submitted by Medline Industries, LP (Nortfield, US). The FDA issued a Cleared decision on January 4, 2024, 266 days after receiving the submission on April 13, 2023. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5630.
| 510(k) Number | K231058 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 13, 2023 |
| Decision Date | January 04, 2024 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | CAF — Nebulizer (direct Patient Interface) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5630 |